A Study of JNJ-64530440 in Healthy Japanese Male Participants
A Double-blind, Placebo-controlled, Randomized, Single Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-64530440 in Healthy Japanese Male Subjects
Sponsor: Janssen Pharmaceutical K.K.
Terminated
Stopped due to a strategic decision.
A PHASE1 clinical study on Healthy, this trial is terminated or withdrawn. The trial is conducted by Janssen Pharmaceutical K.K. and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Mar 2025 — Present [monthly]
Terminated PHASE1
-
Sep 2024 — Mar 2025 [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Feb 2020 — Jan 2021 [monthly]
Terminated PHASE1
Status: Recruiting → Terminated
▶ Show 3 earlier versions
-
Nov 2019 — Feb 2020 [monthly]
Recruiting PHASE1
-
Jun 2019 — Nov 2019 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE1
First recorded
Apr 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Janssen Pharmaceutical K.K.
- Janssen Research & Development, LLC
For direct contact, visit the study record on ClinicalTrials.gov .